- Home
- CABO vs ZLAB Comparison
CABO vs ZLAB Comparison
Compare CABO & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CABO
- ZLAB
- Stock Information
- Founded
- CABO 1980
- ZLAB 2013
- Country
- CABO United States
- ZLAB China
- Employees
- CABO N/A
- ZLAB N/A
- Industry
- CABO Cable & Other Pay Television Services
- ZLAB Biotechnology: Pharmaceutical Preparations
- Sector
- CABO Telecommunications
- ZLAB Health Care
- Exchange
- CABO Nasdaq
- ZLAB Nasdaq
- Market Cap
- CABO 2.0B
- ZLAB 1.8B
- IPO Year
- CABO N/A
- ZLAB 2017
- Fundamental
- Price
- CABO $342.36
- ZLAB $31.24
- Analyst Decision
- CABO Hold
- ZLAB Strong Buy
- Analyst Count
- CABO 5
- ZLAB 4
- Target Price
- CABO $556.40
- ZLAB $52.50
- AVG Volume (30 Days)
- CABO 75.9K
- ZLAB 976.3K
- Earning Date
- CABO 11-07-2024
- ZLAB 11-12-2024
- Dividend Yield
- CABO 3.55%
- ZLAB N/A
- EPS Growth
- CABO 225.28
- ZLAB N/A
- EPS
- CABO 35.76
- ZLAB N/A
- Revenue
- CABO $1,630,937,000.00
- ZLAB $322,711,000.00
- Revenue This Year
- CABO N/A
- ZLAB $48.34
- Revenue Next Year
- CABO N/A
- ZLAB $47.12
- P/E Ratio
- CABO $9.30
- ZLAB N/A
- Revenue Growth
- CABO N/A
- ZLAB 28.16
- 52 Week Low
- CABO $311.28
- ZLAB $13.48
- 52 Week High
- CABO $618.44
- ZLAB $36.60
- Technical
- Relative Strength Index (RSI)
- CABO 45.61
- ZLAB 70.41
- Support Level
- CABO $330.90
- ZLAB $31.52
- Resistance Level
- CABO $350.65
- ZLAB $36.60
- Average True Range (ATR)
- CABO 10.83
- ZLAB 1.36
- MACD
- CABO -0.56
- ZLAB 0.34
- Stochastic Oscillator
- CABO 19.18
- ZLAB 58.60
About CABO Cable One Inc.
Cable One Inc is a telecommunications company. It derives revenue from the provision of broadband, voice, and video services to residential and business customers. From a product perspective, the majority of revenue is sourced from data and video services. This revenue is subscription-based and billed monthly. The company also offers Sparklight TV, an internet protocol-based (IPTV) video service that allows customers with Sparklight TV app to stream video channels from the cloud. The company also derives advertising revenue from selling airtime on its video channels. Voice services are offered over Internet protocols. The company owns a telecommunications infrastructure.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-2306 for treatments across multiple solid tumor types including ovarian and certain types of breast and lung cancers; ZL-2401 which is an antibiotic in a new class of tetracycline derivatives; and ZL-2301 is an oral, small molecule which targets HCC.